Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025442911> ?p ?o ?g. }
- W2025442911 endingPage "330" @default.
- W2025442911 startingPage "320" @default.
- W2025442911 abstract "L-DOPA is the primary drug used to treat Parkinson’s disease (PD) symptoms, but motor side effects limit its long term use. Previous experimental studies show that L-DOPA acts on supersensitive D1 receptors in the basal ganglia to induce extracellular signal-regulated kinases 1 and 2 (ERK1/2), a pair of MAP-kinase proteins that may be involved in induction of motor side effects. Since GABA is known to be intimately involved in basal ganglia function, we investigated whether elevating GABA levels via a GABA-transaminase (GABA-T) inhibitor affects the L-DOPA-induced ERK1/2 phosphorylation in the striatum and substantia nigra (SN) using a rat model of PD. Unilateral dopaminergic lesions of median forebrain bundle neurons were done using the neurotoxin 6-hydroxydopamine. Rats were prescreened for the extent of the lesion by apomorphine-induced rotation test. Lesioned rats were treated with aminooxyacetic acid (AOAA, a GABA-T inhibitor), L-DOPA, or in combination. Immunohistochemistry of tyrosine hydroxylase (TH, a direct indicator of dopaminergic lesion), substance P (SP, an indirect marker that decreases after lesion), and phospho-ERK1/2 was done using slices at the level of striatum and SN. Unilateral dopaminergic lesioned rats, as expected, exhibited >90% TH loss and a modest SP loss in the striatum and SN. L-DOPA alone induced a 343% and 330% increase in phospho-ERK1/2 in the striatum and SN, respectively. We report here a novel finding that pretreatment with AOAA attenuated the L-DOPA induced increase in phospho-ERK1/2 by 62% and 68% in the striatum and SN, respectively, suggesting a DA-GABA-ERK1/2 link in the therapeutic and/or side effects of L-DOPA." @default.
- W2025442911 created "2016-06-24" @default.
- W2025442911 creator A5054932459 @default.
- W2025442911 creator A5068898494 @default.
- W2025442911 date "2013-01-01" @default.
- W2025442911 modified "2023-09-23" @default.
- W2025442911 title "GABA Attenuates L-DOPA-Induced Striatal and Nigral ERK1/2 Signaling in a Rat Model of Parkinson’s Disease" @default.
- W2025442911 cites W1485494038 @default.
- W2025442911 cites W1526160881 @default.
- W2025442911 cites W153061852 @default.
- W2025442911 cites W1539309411 @default.
- W2025442911 cites W1548690558 @default.
- W2025442911 cites W1755157204 @default.
- W2025442911 cites W1951949660 @default.
- W2025442911 cites W1966869556 @default.
- W2025442911 cites W1966901093 @default.
- W2025442911 cites W1966994444 @default.
- W2025442911 cites W1970167407 @default.
- W2025442911 cites W1971908496 @default.
- W2025442911 cites W1973663764 @default.
- W2025442911 cites W1974139119 @default.
- W2025442911 cites W1977533543 @default.
- W2025442911 cites W1981652024 @default.
- W2025442911 cites W1984941820 @default.
- W2025442911 cites W1984983708 @default.
- W2025442911 cites W1990080997 @default.
- W2025442911 cites W1991603311 @default.
- W2025442911 cites W1991935832 @default.
- W2025442911 cites W1996121411 @default.
- W2025442911 cites W1999401390 @default.
- W2025442911 cites W2001295722 @default.
- W2025442911 cites W2002932967 @default.
- W2025442911 cites W2010206955 @default.
- W2025442911 cites W2013018255 @default.
- W2025442911 cites W2015221452 @default.
- W2025442911 cites W2017279410 @default.
- W2025442911 cites W2017400430 @default.
- W2025442911 cites W2025458110 @default.
- W2025442911 cites W2028285705 @default.
- W2025442911 cites W2028727583 @default.
- W2025442911 cites W2030721941 @default.
- W2025442911 cites W2030896691 @default.
- W2025442911 cites W2031872982 @default.
- W2025442911 cites W2033092161 @default.
- W2025442911 cites W2035171463 @default.
- W2025442911 cites W2037199903 @default.
- W2025442911 cites W2046047050 @default.
- W2025442911 cites W2052887259 @default.
- W2025442911 cites W2052953036 @default.
- W2025442911 cites W2060241252 @default.
- W2025442911 cites W2061036786 @default.
- W2025442911 cites W2061580592 @default.
- W2025442911 cites W2063729355 @default.
- W2025442911 cites W2063936896 @default.
- W2025442911 cites W2065197060 @default.
- W2025442911 cites W2071948878 @default.
- W2025442911 cites W2073618643 @default.
- W2025442911 cites W2075361934 @default.
- W2025442911 cites W2078288361 @default.
- W2025442911 cites W2085741616 @default.
- W2025442911 cites W2085743799 @default.
- W2025442911 cites W2088619016 @default.
- W2025442911 cites W2089156720 @default.
- W2025442911 cites W2091741039 @default.
- W2025442911 cites W2092634694 @default.
- W2025442911 cites W2095035585 @default.
- W2025442911 cites W2101392799 @default.
- W2025442911 cites W2107758668 @default.
- W2025442911 cites W2111885726 @default.
- W2025442911 cites W2115222037 @default.
- W2025442911 cites W2122946342 @default.
- W2025442911 cites W2129927715 @default.
- W2025442911 cites W2130138967 @default.
- W2025442911 cites W2133697996 @default.
- W2025442911 cites W2143656230 @default.
- W2025442911 cites W2150030587 @default.
- W2025442911 cites W2150681175 @default.
- W2025442911 cites W2156634902 @default.
- W2025442911 cites W2159891593 @default.
- W2025442911 cites W2161197727 @default.
- W2025442911 cites W2163724813 @default.
- W2025442911 cites W2163815564 @default.
- W2025442911 cites W2164158899 @default.
- W2025442911 cites W2168216500 @default.
- W2025442911 cites W2210106991 @default.
- W2025442911 cites W2319256886 @default.
- W2025442911 cites W2399402971 @default.
- W2025442911 cites W2419341280 @default.
- W2025442911 cites W2745956054 @default.
- W2025442911 cites W2248274661 @default.
- W2025442911 doi "https://doi.org/10.4236/jbbs.2013.33032" @default.
- W2025442911 hasPublicationYear "2013" @default.
- W2025442911 type Work @default.
- W2025442911 sameAs 2025442911 @default.
- W2025442911 citedByCount "1" @default.
- W2025442911 countsByYear W20254429112013 @default.
- W2025442911 crossrefType "journal-article" @default.
- W2025442911 hasAuthorship W2025442911A5054932459 @default.